Literature DB >> 22681252

Functional selectivity in GPCR signaling: understanding the full spectrum of receptor conformations.

E Goupil1, S A Laporte, T E Hébert.   

Abstract

The great versatility of G protein-coupled receptors (GPCRs), in terms of both their ability to bind different types of ligands and initiate a large number of distinct cellular signaling events, remains incompletely understood. In recent years, the classical view of the nature and consequences of ligand binding to GPCRs has dramatically changed. The notion of functional selectivity, achieved through both biased ligands and allosteric modulators, has brought substantial new insight into our comprehension of the pluridimensionality of signaling achieved by GPCRs. Moreover, receptor heterodimerization adds another important dimension to the diversity of cellular responses controlled by GPCRs. Here, we review these considerations and discuss how they will impact the design of improved therapeutics.

Mesh:

Substances:

Year:  2012        PMID: 22681252     DOI: 10.2174/138955712800959143

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  13 in total

Review 1.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

Review 2.  Neoclerodanes as atypical opioid receptor ligands.

Authors:  Thomas E Prisinzano
Journal:  J Med Chem       Date:  2013-04-18       Impact factor: 7.446

3.  Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration.

Authors:  Laila A Al-Alwan; Ying Chang; Andrea Mogas; Andrew J Halayko; Carolyn J Baglole; James G Martin; Simon Rousseau; David H Eidelman; Qutayba Hamid
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

Review 4.  International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

5.  Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors.

Authors:  Rory Sleno; Dominic Devost; Darlaine Pétrin; Alice Zhang; Kyla Bourque; Yuji Shinjo; Junken Aoki; Asuka Inoue; Terence E Hébert
Journal:  J Biol Chem       Date:  2017-06-05       Impact factor: 5.157

6.  Development of a human antibody that exhibits antagonistic activity toward CC chemokine receptor 7.

Authors:  Moon-Sung Jang; Nurain Syahirah Binti Ismail; Yeon Gyu Yu
Journal:  Antib Ther       Date:  2022-07-21

Review 7.  Emerging roles of GPER in diabetes and atherosclerosis.

Authors:  Matthias Barton; Eric R Prossnitz
Journal:  Trends Endocrinol Metab       Date:  2015-03-09       Impact factor: 12.015

8.  The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects.

Authors:  Lirit N Franks; Benjamin M Ford; Toshifumi Fujiwara; Haibo Zhao; Paul L Prather
Journal:  Toxicol Appl Pharmacol       Date:  2018-06-12       Impact factor: 4.219

Review 9.  Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs.

Authors:  H J Dranse; M E M Kelly; B D Hudson
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

10.  GPCR Heterodimerization in the Reproductive System: Functional Regulation and Implication for Biodiversity.

Authors:  Honoo Satake; Shin Matsubara; Masato Aoyama; Tsuyoshi Kawada; Tsubasa Sakai
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-15       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.